Is Sonoma Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: SNOA) stock is to Strong Buy SNOA stock.
Out of 1 analyst, 1 (100%) are recommending SNOA as a Strong Buy, 0 (0%) are recommending SNOA as a Buy, 0 (0%) are recommending SNOA as a Hold, 0 (0%) are recommending SNOA as a Sell, and 0 (0%) are recommending SNOA as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year SNOA price target, the average SNOA price target is $3.25, with the highest SNOA stock price forecast at $3.25 and the lowest SNOA stock price forecast at $3.25.
The Wall Street analyst predicted that Sonoma Pharmaceuticals's share price could reach $3.25 by Sep 5, 2024. The average Sonoma Pharmaceuticals stock price prediction forecasts a potential upside of 1,695.58% from the current SNOA share price of $0.18.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.